Federal lawsuits against Allergan’s Natrelle Biocell Textured Breast Implants emerged months after its manufacturer, Allergan, recalled it. The U.S. Judicial Panel on Multidistrict Litigation consolidated all federal into an MDL class action in New Jersey (most recent court order). The MDL lawsuits allege that the implants cause breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare form of cancer.
February 3, 2024: There are now a total of 1,201 cases pending in the Allergan breast implant class action MDL in federal court. This MDL has only averaged 9 new cases per month since last summer.